tiprankstipranks
NextCure Inc (NXTC)
NASDAQ:NXTC
US Market

NextCure (NXTC) Income Statement

Compare
295 Followers

NextCure Income Statement

Last quarter (Q3 2024), NextCure's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NextCure's net income was $-11.54M. See NextCure’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 22.38M$ 6.35M
Gross Profit
$ -3.68M$ -4.48M$ -4.30M$ 22.33M$ 6.31M
Operating Expenses
$ 67.64M$ 75.91M$ 70.77M$ 63.60M$ 43.83M
Depreciation and Amortization
$ 3.68M$ 4.48M$ 4.30M$ 3.41M$ 2.69M
EBITDA
$ -59.04M$ -70.25M$ -65.01M$ -37.81M$ -34.79M
Operating Income
$ -67.64M$ -75.91M$ -70.77M$ -41.23M$ -37.48M
Other Income/Expenses
$ 4.91M$ 1.18M$ 1.38M$ 4.62M$ 3.75M
Pretax Income
$ -62.72M$ -74.73M$ -69.39M$ -36.60M$ -33.74M
Net Income
$ -62.72M$ -69.43M$ -69.39M$ -33.19M$ -33.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.25$ -2.50$ -2.51$ -1.21$ -2.15
Diluted EPS
$ -2.25$ -2.50$ -2.51$ -1.21$ -2.15
Weighted Average Shares Outstanding
27.84M 27.74M 27.62M 27.53M 15.70M
Weighted Average Shares Outstanding (Diluted)
27.84M 27.74M 27.62M 27.53M 15.70M
Currency in USD

NextCure Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis